GBR 12935
Modify Date: 2024-01-02 08:55:18
GBR 12935 structure
|
Common Name | GBR 12935 | ||
|---|---|---|---|---|
| CAS Number | 76778-22-8 | Molecular Weight | 414.58 | |
| Density | 1.067g/cm3 | Boiling Point | 540.6ºC at 760 mmHg | |
| Molecular Formula | C28H34N2O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 143.9ºC | |
Use of GBR 12935GBR 12935 is a potent, and selective dopamine reuptake inhibitor.IC50 value: Target: dopamine reuptake inhibitorin vitro: The calculated Kd of [3H]GBR-12935 binding to CYP2D6 was 42.2 nM, indicating that GBR-12935 has a high affinity for CYP2D6. The binding of [3H]GBR-12935 to CYP2D6 was decreased partially by substrates or inhibitors of CYP2D isoforms (quinine, quinidine, propranolol, bufuralol, imipramine, and desipramine) [1]. Co-perfusion of 100 microM GBR 12909 or GBR 12935 with either 100 microM sulpiride or raclopride produced a significant reduction in the GBR 12909 or GBR 12935 induced increase in the extracellular levels of dopamine to basal levels. In vitro, GBR 12909 (1-9 nM) dose-dependently inhibited active uptake of [3H]dopamine in homogenates of the nucleus accumbens [2].in vivo: GBR 12935 elevated locomotion to a greater extent in C57BL/6J mice at the maximally active dose of 10 mg/kg. Locomotor stimulation by GBR 12935 remained consistent in both strains with repeated injections. DBA/2J mice became sensitized to cocaine-induced stereotypy with repeated injections. Cocaine induced no stereotypy in C57BL/6J mice on any test day. No stereotypies were induced by GBR 12935 in either strain on any test day [3]. |
| Name | 1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine |
|---|---|
| Synonym | More Synonyms |
| Description | GBR 12935 is a potent, and selective dopamine reuptake inhibitor.IC50 value: Target: dopamine reuptake inhibitorin vitro: The calculated Kd of [3H]GBR-12935 binding to CYP2D6 was 42.2 nM, indicating that GBR-12935 has a high affinity for CYP2D6. The binding of [3H]GBR-12935 to CYP2D6 was decreased partially by substrates or inhibitors of CYP2D isoforms (quinine, quinidine, propranolol, bufuralol, imipramine, and desipramine) [1]. Co-perfusion of 100 microM GBR 12909 or GBR 12935 with either 100 microM sulpiride or raclopride produced a significant reduction in the GBR 12909 or GBR 12935 induced increase in the extracellular levels of dopamine to basal levels. In vitro, GBR 12909 (1-9 nM) dose-dependently inhibited active uptake of [3H]dopamine in homogenates of the nucleus accumbens [2].in vivo: GBR 12935 elevated locomotion to a greater extent in C57BL/6J mice at the maximally active dose of 10 mg/kg. Locomotor stimulation by GBR 12935 remained consistent in both strains with repeated injections. DBA/2J mice became sensitized to cocaine-induced stereotypy with repeated injections. Cocaine induced no stereotypy in C57BL/6J mice on any test day. No stereotypies were induced by GBR 12935 in either strain on any test day [3]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.067g/cm3 |
|---|---|
| Boiling Point | 540.6ºC at 760 mmHg |
| Molecular Formula | C28H34N2O |
| Molecular Weight | 414.58 |
| Flash Point | 143.9ºC |
| PSA | 90.31000 |
| LogP | 4.63060 |
| Index of Refraction | 1.576 |
| Storage condition | 2-8℃ |
| HS Code | 2933599090 |
|---|
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (2Z)-but-2-enedioate (1:1) |
| Piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)-, (2Z)-2-butenedioate (1:1) |
| 1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine (2Z)-2-butenedioate (1:1) |
| 1-(2-benzhydryloxy-ethyl)-4-(3-phenyl-propyl)-piperazine |
| Piperazine,1-(2-(diphenylmethoxy)ethyl)-4-(3-phenylpropyl) |
| N-[3-tert-Butyl-1-(4-Methylphenyl)-1H-pyrazol-5-yl]-N-[4-[2-(4-Morpholinyl)ethoxy]naphthalen-1-yl]urea |
| 1-Hydrocinnamyl-4-[2-(diphenylmethoxy)ethyl]piperazine |
| 1-(2-(diphenylmethoxy)-ethyl)-4-(3-phenylpropyl)piperazine |
| 1-(2-(Benzhydryloxy)ethyl)-4-(3-phenylpropyl)piperazine maleate |
| GBR 12935 |